{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:28:51Z","timestamp":1784014131899,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["airmedicaljournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Air Medical Journal"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.amj.2024.03.012","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T03:21:44Z","timestamp":1714879304000},"page":"348-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell\u2013Containing Products to Females of Childbearing Potential"],"prefix":"10.1016","volume":"43","author":[{"given":"Michael P.","family":"McCartin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.","family":"Wool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Panfil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira J.","family":"Blumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L.","family":"Tataris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amj.2024.03.012_bib0001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.amj.2024.03.012_bib0002","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/2013.jamasurg.387","article-title":"The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks","volume":"148","author":"Holcomb","year":"2013","journal-title":"JAMA Surg"},{"key":"10.1016\/j.amj.2024.03.012_bib0003","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2017.15097","article-title":"Association of prehospital blood product transfusion during medical evacuation of combat casualties in Afghanistan with acute and 30-day survival","volume":"318","author":"Shackelford","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.amj.2024.03.012_bib0004","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jamcollsurg.2015.01.006","article-title":"Pre-trauma center red blood cell transfusion is associated with improved early outcomes in air medical trauma patients","volume":"220","author":"Brown","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.amj.2024.03.012_bib0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/TA.0000000000001078","article-title":"Shorter times to packed red blood cell transfusion are associated with decreased risk of death in traumatically injured patients","volume":"81","author":"Powell","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.amj.2024.03.012_bib0006","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13049-018-0567-1","article-title":"Mortality of civilian patients with suspected traumatic haemorrhage receiving pre-hospital transfusion of packed red blood cells compared to pre-hospital crystalloid","volume":"26","author":"Griggs","year":"2018","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.amj.2024.03.012_bib0007","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJMoa1802345","article-title":"Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock","volume":"379","author":"Sperry","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amj.2024.03.012_bib0008","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(18)31553-8","article-title":"Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial","volume":"392","author":"Moore","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.amj.2024.03.012_bib0009","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2352-3026(22)00040-0","article-title":"Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"9","author":"Crombie","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.amj.2024.03.012_bib0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1213\/ANE.0000000000005747","article-title":"Pro-con debate: prehospital blood transfusion-should it be adopted for civilian trauma?","volume":"134","author":"Dudaryk","year":"2022","journal-title":"Anesth Analg"},{"key":"10.1016\/j.amj.2024.03.012_bib0011","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2352-3026(22)00074-6","article-title":"Prehospital blood transfusion: who benefits?","volume":"9","author":"Thies","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.amj.2024.03.012_bib0012","unstructured":"TOWAR. What is TOWAR? Available at: https:\/\/www.litesnetwork.org\/towar\/. Accessed January 8, 2024."},{"key":"10.1016\/j.amj.2024.03.012_bib0013","unstructured":"American Red Cross. Blood shortage continues, please give blood now. Available at:https:\/\/www.redcross.org\/about-us\/news-and-events\/press-release\/2023\/red-cross-announces-national-blood-shortage.html. Accessed November 14, 2023."},{"issue":"suppl 4","key":"10.1016\/j.amj.2024.03.012_bib0014","first-page":"S8","article-title":"Continued stabilization of blood collections and transfusions in the United States: findings from the 2021 National Blood Collection and Utilization Survey","volume":"63","author":"Free","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/j.amj.2024.03.012_bib0015","unstructured":"Paxton A. The way forward for prehospital transfusion. December 2022. Available at:https:\/\/www.captodayonline.com\/the-way-forward-for-prehospital-transfusion\/. Accessed February 16, 2024."},{"key":"10.1016\/j.amj.2024.03.012_bib0016","series-title":"Erythroblastosis Fetalis","author":"Nassar","year":"2023"},{"key":"10.1016\/j.amj.2024.03.012_bib0017","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1111\/trf.15569","article-title":"It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies","volume":"59","author":"Yazer","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.amj.2024.03.012_bib0018","doi-asserted-by":"crossref","first-page":"789","DOI":"10.31557\/APJCP.2019.20.3.789","article-title":"Validation of the accuracy of self-reported ABO blood types in the Japan Nurses\u2019 Health Study","volume":"20","author":"Alkebsi","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.amj.2024.03.012_bib0019","unstructured":"Rhophylac: full prescribing information. Available at:https:\/\/labeling.cslbehring.com\/PI\/US\/Rhophylac\/EN\/Rhophylac-Prescribing-Information.pdf. Accessed October 12, 2023."},{"key":"10.1016\/j.amj.2024.03.012_bib0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/0002-9378(86)90725-8","article-title":"Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women","volume":"154","author":"Stedman","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amj.2024.03.012_bib0021","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.0041-1132.2004.04161.x","article-title":"Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin","volume":"44","author":"Nester","year":"2004","journal-title":"Transfusion"},{"issue":"suppl 1","key":"10.1016\/j.amj.2024.03.012_bib0022","first-page":"S80","article-title":"The regional whole blood program in San Antonio, TX: a 3-year update on prehospital and in-hospital transfusion practices for traumatic and non-traumatic hemorrhage","volume":"62","author":"Braverman","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/j.amj.2024.03.012_bib0023","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.amj.2024.03.012_bib0024","series-title":"Hemolytic Disease of the Newborn","author":"Hall","year":"2024"},{"key":"10.1016\/j.amj.2024.03.012_bib0025","series-title":"Blood Groups and Red Cell Antigens","author":"Dean","year":"2005"},{"key":"10.1016\/j.amj.2024.03.012_bib0026","first-page":"50","article-title":"McMaster Conference on Prevention of Rh Immunization 28\u201330 September, 1977","volume":"36","year":"1979","journal-title":"Vox Sang"},{"issue":"suppl 18","key":"10.1016\/j.amj.2024.03.012_bib0027","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1471-0528.1998.tb10285.x","article-title":"The prevention of Rh haemolytic disease of the fetus and newborn\u2013general background","volume":"105","author":"Contreras","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.amj.2024.03.012_bib0028","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1203\/00006450-198611000-00004","article-title":"Blood group antigens on fetal red cells obtained by umbilical vein puncture under ultrasound guidance: a rapid hemagglutination test to check for contamination with maternal blood","volume":"20","author":"Habibi","year":"1986","journal-title":"Pediatr Res"},{"key":"10.1016\/j.amj.2024.03.012_bib0029","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.1.5696.593","article-title":"Primary immunization of Rh-negative volunteers","volume":"1","author":"Gunson","year":"1970","journal-title":"Br Med J"},{"issue":"suppl 1","key":"10.1016\/j.amj.2024.03.012_bib0030","first-page":"S185","article-title":"Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: the BEST collaborative study","volume":"62","author":"Seheult","year":"2022","journal-title":"Transfusion"},{"issue":"suppl 1","key":"10.1016\/j.amj.2024.03.012_bib0031","first-page":"S144","article-title":"Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury","volume":"61","author":"Raval","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.amj.2024.03.012_bib0032","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/16078454.2021.1905395","article-title":"Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review","volume":"26","author":"Yazer","year":"2021","journal-title":"Hematology"},{"key":"10.1016\/j.amj.2024.03.012_bib0033","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1111\/trf.17330","article-title":"Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients","volume":"63","author":"Yazer","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/j.amj.2024.03.012_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000020.pub2","article-title":"Anti-D administration in pregnancy for preventing Rhesus alloimmunisation","volume":"2","author":"Crowther","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amj.2024.03.012_bib0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/tme.12091","article-title":"BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn","volume":"24","author":"Qureshi","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.amj.2024.03.012_bib0036","series-title":"Rho(D) Immune Globulin","author":"Yoham","year":"2023"},{"key":"10.1016\/j.amj.2024.03.012_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102950","article-title":"RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates","volume":"59","author":"Legler","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.amj.2024.03.012_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJWH.S390661","article-title":"Management of wrong blood transfusion to an RhD negative woman in labor","volume":"15","author":"Titze","year":"2023","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.amj.2024.03.012_bib0039","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12288-021-01506-w","article-title":"Anti-D alloimmunization after RhD positive red cell transfusion to selected RhD negative patients","volume":"38","author":"Pandey","year":"2022","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.amj.2024.03.012_bib0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pd.5355","article-title":"The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization","volume":"38","author":"Zwiers","year":"2018","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.amj.2024.03.012_bib0041","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/trf.17209","article-title":"Primum, non nocere: whole blood, prehospital transfusion and anti-D hemolytic disease of the fetus and newborn","volume":"63","author":"O'Brien","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/j.amj.2024.03.012_bib0042","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1537-2995.2008.01742.x","article-title":"One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.amj.2024.03.012_bib0043","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/j.2205-0140.2009.tb00058.x","article-title":"Middle cerebral artery Doppler","volume":"12","author":"Brennand","year":"2009","journal-title":"Australas J Ultrasound Med"},{"key":"10.1016\/j.amj.2024.03.012_bib0044","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amj.2024.03.012_bib0045","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1067\/mob.2002.127310","article-title":"Longitudinal assessment of the middle cerebral artery peak systolic velocity in healthy fetuses and in fetuses at risk for anemia","volume":"187","author":"Detti","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amj.2024.03.012_bib0046","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/17474086.2017.1305265","article-title":"Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn \u2013 review on current management and outcome","volume":"10","author":"Zwiers","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.amj.2024.03.012_bib0047","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures","volume":"50","author":"Zwiers","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.amj.2024.03.012_bib0048","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0002-9378(89)90386-4","article-title":"Two hundred intrauterine exchange transfusions in severe blood incompatibilities","volume":"161","author":"Poissonnier","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amj.2024.03.012_bib0049","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2016.03.037","article-title":"In utero treatment of severe fetal anemia resulting from fetomaternal red blood cell incompatibility: a comparison of simple transfusion and exchange transfusion","volume":"201","author":"Guilbaud","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.amj.2024.03.012_bib0050","article-title":"Alloimmune hemolytic disease of the newborn: postnatal diagnosis and management","author":"Calhoun","year":"2023","journal-title":"UpToDate"}],"container-title":["Air Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1067991X24000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1067991X24000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T07:56:24Z","timestamp":1734162984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1067991X24000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1067991X24000609"],"URL":"https:\/\/doi.org\/10.1016\/j.amj.2024.03.012","relation":{},"ISSN":["1067-991X"],"issn-type":[{"value":"1067-991X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell\u2013Containing Products to Females of Childbearing Potential","name":"articletitle","label":"Article Title"},{"value":"Air Medical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amj.2024.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Air Medical Journal Associates. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}